Cardinal Health, Inc.
As of Fiscal Year 2025 (ended June 30, 2025)
Key KPIs at a Glance
| Metric | Value |
|---|---|
| Total revenue (FY2025) | $222.578 billion, down 1.9% year-over-year from $226.827B, driven mainly by the expiration of a large pharmaceutical distribution customer contract (revenue excluding that item grew ~18%, per company disclosure) |
| Net income, GAAP (FY2025) | $1.561 billion, up 83% year-over-year from $852 million |
| Gross margin (FY2025) | $8.168 billion, or about 3.7% of total revenue |
| Operating earnings, GAAP (FY2025) | $2.275 billion, or about 1.0% of total revenue (operating margin); non-GAAP operating earnings were $2.786 billion, up 15% year-over-year |
| Diluted EPS, GAAP (FY2025) | $6.45, up 87% year-over-year from $3.45 |
| Diluted EPS, non-GAAP (FY2025) | $8.24, up 9% year-over-year from $7.53 |
| Dividends paid per share (FY2025) | $2.0224 (four quarterly payments of $0.5056); quarterly dividend subsequently raised to $0.5107, effective the July 2025 payment (FY2026) |
| Employees | ~57,700 employees worldwide as of June 30, 2025 (third-party aggregation of company disclosures; roughly three-quarters U.S.-based) |
| Distribution scale | Serves the large majority of U.S. hospitals and tens of thousands of pharmacies, physician offices and clinics, with roughly 40,000 pharmaceutical deliveries per day; figures are third-party/company-marketing estimates, not audited financial metrics, and are not FY2025-specific |
Sources: All FY2025 figures are GAAP actuals as reported in Cardinal Health's Q4/FY2025 earnings release (Aug 12, 2025) and its FY2025 Form 10-K (fiscal year ended June 30, 2025). Cardinal Health's fiscal year runs July 1-June 30, so FY2025 covers July 2024-June 2025, not calendar 2025. Segment revenue and segment profit figures are company-disclosed in the earnings release segment table and 10-K segment footnote. Prior-year revenue history (FY2021-FY2024) is drawn from each respective year's 10-K/earnings release, using the comparative figures as restated in the FY2024 Form 10-K where available. Employee count (~57,700) and distribution-scale stats (e.g., hospital/pharmacy reach, daily deliveries) are third-party aggregations (company fact sheets and industry trackers) rather than line items in the 10-K's financial statements, and should be read as approximate as of mid-to-late FY2025. For run-rate context: Cardinal Health has since fully reported FY2026 (ended June 30, 2026) -- revenue of $254.2 billion (+14% YoY), GAAP net income of $1.714 billion -- indicating a significant reacceleration in revenue and profit growth versus the FY2025 figures presented here, which were depressed by the roll-off/expiration of a large pharmaceutical distribution customer contract.